Design of customized coronavirus receptors.

Peng Liu1 Mei-Ling Huang1 Hua Guo2 Matthew McCallum3 Jun-Yu Si1 Yuan-Mei Chen1 Chun-Li Wang1 Xiao Yu1 Lu-Lu Shi1 Qing Xiong1 Cheng-Bao Ma1 John E Bowen3 Fei Tong1 Chen Liu1 Ye-Hui Sun1 Xiao Yang1 Jing Chen2 Ming Guo1 Jing Li1 Davide Corti4 David Veesler5,6 Zheng-Li Shi7,8 Huan Yan9
Affiliations 9 institutions
  1. State Key Laboratory of Virology, College of Life Sciences, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, China.
  2. Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
  3. Department of Biochemistry, University of Washington, Seattle, WA, USA.
  4. Humabs BioMed SA, subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  5. Department of Biochemistry, University of Washington, Seattle, WA, USA. [email protected].
  6. Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA. [email protected].
  7. Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China. [email protected].
  8. Guangzhou Laboratory, Guangzhou International Bio Island, Guangzhou, China. [email protected].
  9. State Key Laboratory of Virology, College of Life Sciences, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, China. [email protected].

Abstract

Although coronaviruses use diverse receptors, the characterization of coronaviruses with unknown receptors has been impeded by a lack of infection models1,2. Here we introduce a strategy to engineer functional customized viral receptors (CVRs). The modular design relies on building artificial receptor scaffolds comprising various modules and generating specific virus-binding domains. We identify key factors for CVRs to functionally mimic native receptors by facilitating spike proteolytic cleavage, membrane fusion, pseudovirus entry and propagation for various coronaviruses. We delineate functional SARS-CoV-2 spike receptor-binding sites for CVR design and reveal the mechanism of cell entry promoted by the N-terminal domain-targeting S2L20-CVR. We generated CVR-expressing cells for 12 representative coronaviruses from 6 subgenera, most of which lack known receptors, and show that a pan-sarbecovirus CVR supports propagation of a propagation-competent HKU3 pseudovirus and of authentic RsHuB2019A3. Using an HKU5-specific CVR, we successfully rescued wild-type and ZsGreen-HiBiT-incorporated HKU5-1 (LMH03f) and isolated a HKU5 strain from bat samples. Our study demonstrates the potential of the CVR strategy for establishing native receptor-independent infection models, providing a tool for studying viruses that lack known susceptible target cells.

Supporting text Virus Host Location
Coronavirus 92 Models, Biological 16 Protein Engineering 2 Receptors, Coronavirus 6 Virus Internalization 100 Animals 1948 Binding Sites 89 Cell Line 158 Humans 1440 Protein Binding 193 Protein Domains 45 SARS-CoV-2 453 Spike Glycoprotein, Coronavirus 274 spike protein, SARS-CoV-2 157

Evidence records

2 total
Zoonotic Surveillance
1 records · 1 evidence types
Evidence type
1 records
OVE8532
Key finding

An HKU5 strain was successfully isolated from bat samples using an HKU5-specific customized viral receptor system.

Virus
Host
Location
Not specified
Supporting text

Using an HKU5-specific CVR, we successfully rescued wild-type and ZsGreen-HiBiT-incorporated HKU5-1 (LMH03f) and isolated a HKU5 strain from bat samples.

Sample type
bat samples
Experimental Infection
1 records · 1 evidence types
Evidence type
1 records
OVE8533
Key finding

CVR-expressing cells supported entry and propagation of HKU3 pseudovirus and authentic RsHuB2019A, demonstrating experimental susceptibility across coronaviruses using engineered receptors.

Virus
Host
Location
Not specified
Supporting text

We generated CVR-expressing cells for 12 representative coronaviruses from 6 subgenera, most of which lack known receptors, and show that a pan-sarbecovirus CVR supports propagation of a propagation‑competent HKU3 pseudovirus and of authentic RsHuB2019A.

Method
pseudovirus entry assay | viral propagation test | receptor engineering (CVR)
Sample type
cell culture system
Experimental system
engineered receptor-expressing cell model (CVR cells)